July 7, 2020 -- Li-Cor Biosciences offers research solutions for therapeutics development and western blotting. Now, the company is offering researchers a special Odyssey Clx Viral Solution package at a reduced price to support COVID-19 research.
Traditionally, researchers use plaque assays to determine infectivity of SARS-CoV-2 and other viruses. Alternatively, Li-Cor's near-infrared western blot and in-cell western assays offer a rapid and reliable method to study viruses like SARS-CoV-2.
The package includes the Odyssey Imager, startup reagents, basic and advanced virtual training from Li-Cor scientists, and Empiria Studio statistical analysis software.
Copyright © 2020 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
